These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 3106227)

  • 1. [Clinical study of the effectiveness and tolerance of norfloxacin in the therapy of complicated urinary tract infections and in long-term prevention of recurrent urinary tract infections].
    Westenfelder M; Pelz K; Frankenschmidt A; Vahlensieck W
    Infection; 1987; 15(1):20-4. PubMed ID: 3106227
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Clinical experience of norfloxacin in urinary tract infection].
    Banya Y; Funaki H; Takagane H; Tanji S; Abe T; Aoki H; Kubo T; Ohori T
    Hinyokika Kiyo; 1985 Aug; 31(8):1501-17. PubMed ID: 4083210
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Clinical studies of norfloxacin in urinary tract infections].
    Matsuura T; Kurita T
    Hinyokika Kiyo; 1985 Nov; 31(11):2085-9. PubMed ID: 4091145
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Clinical evaluation of norfloxacin preparation in treatment of bacterial infections of the urinary tract in patients with various kidney diseases].
    Mazanowska O; Boratyńska M; Mróz E; Starek J
    Pol Tyg Lek; 1994 Feb 7-14; 49(6-7):154-7. PubMed ID: 8090671
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Norfloxacin treatment in complicated urinary tract infection.
    Boerema JB; van Saene HK
    Scand J Infect Dis Suppl; 1986; 48():20-6. PubMed ID: 3465030
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Review of norfloxacin in complicated and recurrent urinary tract infections.
    Schaeffer AJ
    Eur Urol; 1990; 17 Suppl 1():19-23. PubMed ID: 2191865
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Norfloxacin in the treatment of urinary tract infections].
    Joost J
    Wien Klin Wochenschr; 1986 May; 98(11):355-7. PubMed ID: 3524016
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Low-dose norfloxacin versus placebo for long-term prophylaxis of recurrent uncomplicated urinary tract infection.
    Rugendorff E; Haralambie E
    Chemioterapia; 1987 Jun; 6(2 Suppl):533-5. PubMed ID: 3334616
    [No Abstract]   [Full Text] [Related]  

  • 9. [Comparative evaluation of norfloxacin and cinoxacin in the therapy of complicated infections of the urinary tract].
    Cristiano P; Morelli G; Simioli F; Iovene MR; Della Vittoria Scarpati M; Manguso L
    Minerva Med; 1989 Apr; 80(4):393-5. PubMed ID: 2657499
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Safety and efficacy of lomefloxacin versus norfloxacin in the treatment of complicated urinary tract infections.
    Hoepelman IM; Havinga WH; Benne RA; Zwinkels M; de Wit MA; de Hond HA; Boon TA; Visser MR; van Asbeck FW; Verhoef J
    Eur J Clin Microbiol Infect Dis; 1993 May; 12(5):343-7. PubMed ID: 8394815
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Norfloxacin versus parenteral therapy in the treatment of complicated urinary tract infections and resistant organisms.
    Cherubin C; Stilwell S
    Scand J Infect Dis Suppl; 1986; 48():32-7. PubMed ID: 3535053
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prevention of bacterial resistance in urinary tract infections.
    Goldstein EJ
    Eur Urol; 1991; 19 Suppl 1():28-32. PubMed ID: 2022230
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy and tolerability of norfloxacin vs. ciprofloxacin in complicated urinary tract infection.
    Schaeffer AJ; Anderson RU
    Urology; 1992 Nov; 40(5):446-9. PubMed ID: 1441044
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparative trial of norfloxacin and macrocrystalline nitrofurantoin (Macrodantin) in the prophylaxis of recurrent urinary tract infection in women.
    Brumfitt W; Hamilton-Miller JM; Smith GW; al-Wali W
    Q J Med; 1991 Oct; 81(294):811-20. PubMed ID: 1801054
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Norfloxacin in the treatment of urinary tract infections in men with and without identifiable urologic complications.
    Corrado ML; Grad C; Sabbaj J
    Am J Med; 1987 Jun; 82(6B):70-4. PubMed ID: 3300314
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Patient compliance and efficacy of low-dose, long-term prophylaxis in patients with recurrent urinary tract infection.
    Westenfelder M; Vahlensieck W; Reinhartz U
    Chemioterapia; 1987 Jun; 6(2 Suppl):530-2. PubMed ID: 3509492
    [No Abstract]   [Full Text] [Related]  

  • 17. Treatment of recurrent urinary tract infection with norfloxacin versus trimethoprim-sulfamethoxazole.
    Seidmon EJ; Krisch EB; Truant AL; Amy BG; Childs SJ; Hurst AT; McCabe RE
    Urology; 1990 Feb; 35(2):187-93. PubMed ID: 2407023
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Coordinated multicenter study of norfloxacin versus trimethoprim-sulfamethoxazole treatment of symptomatic urinary tract infections. The Urinary Tract Infection Study Group.
    J Infect Dis; 1987 Feb; 155(2):170-7. PubMed ID: 2879872
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effective postcoital quinolone prophylaxis of recurrent urinary tract infections in women.
    Pfau A; Sacks TG
    J Urol; 1994 Jul; 152(1):136-8. PubMed ID: 8201643
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Norfloxacin versus co-trimoxazole in the treatment of recurring urinary tract infections in men.
    Sabbaj J; Hoagland VL; Cook T
    Scand J Infect Dis Suppl; 1986; 48():48-53. PubMed ID: 3490684
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.